News
Incyte Corp.’s Zynyz (retifanlimab-dlwr) has received another U.S. FDA approval and put some distance between it and a 2021 ...
The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...
After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.
Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.
Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...
Paul Craig says he developed an eating disorder while cutting weight to reach middleweight and urges any fighter who has ...
4d
Medical Device Network on MSNThe impact of bio-convergence in healthcareBiomed Israel 2025: the 23rd National Life Science & Technology Week is taking place in Tel Aviv, between 20 and 22 May.
Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a ...
While some details are still uncertain, test-tube studies have shown that reishi can affect the genes in white blood cells, which are critical parts of your immune system. What’s more ...
Access includes Asimov’s CHO Edge cell line development platform and Cytiva’s HyClone™ media and feed solutions, along with Cytiva’s Fast Trak™ process development services.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results